Glycophos (Fresenius Kabi USA, LLC)
Welcome to the PulseAid listing for the Glycophos drug offered from Fresenius Kabi USA, LLC. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Fresenius Kabi USA, LLC |
| NON-PROPRIETARY NAME: | SODIUM GLYCOLATE |
| SUBSTANCE NAME: | SODIUM GLYCEROPHOSPHATE ANHYDROUS |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | INTRAVENOUS; INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE |
| START MARKETING DATE: | 2013-05-13 |
| END MARKETING DATE: | 0000-00-00 |
Glycophos HUMAN PRESCRIPTION DRUG Details:
| Item Description | Glycophos from Fresenius Kabi USA, LLC |
| LABELER NAME: | Fresenius Kabi USA, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 216(mg/mL) |
| START MARKETING DATE: | 2013-05-13 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63323-241_0bc61980-d4a9-4b9a-864b-d4a25cbe49e0 |
| PRODUCT NDC: | 63323-241 |
| APPLICATION NUMBER: | |
Other SODIUM GLYCEROPHOSPHATE ANHYDROUS Pharmaceutical Manufacturers / Labelers:
